Popular Diabetes Drug CAUSING Heart Attacks?!
Leave it to Big Pharma to sell you one drug to help prevent heart attacks… and another that can CAUSE them.
That’s right. A popular diabetes drug can increase your risk of numerous types of heart issues… including heart attacks.
Big Pharma has known about this risk for years—and the drug is banned in Europe.
So then why are doctors in the US still prescribing it?
The type 2 diabetes drug rosiglitazone was on the market for seven whole years before studies came to light showing that it increased the risk of heart failure and heart attack.
These studies were enough to have the drug pulled from the market in Europe.
Yet this heart-attack-in-a-bottle is still available in the US.
Yes, it has a warning label on its packaging. And yes, the FDA has restricted its availability.
But the FDA has stopped short of pulling it from the market because some safety studies showed “mixed results.”
Now, a new study published in the BMJ has finally set the record straight.
This study analyzed over 130 randomized, controlled clinical trials including 48,000 patients that compared Avandia to either other drugs or a placebo.
Ultimately, they found that people taking rosiglitazone had a 33 percent higher risk of:
- Heart attack
- Heart failure
- Cardiovascular deaths, and
- Non-cardiovascular related deaths
In other words, there’s a good chance this drug could kill you.
I’m not a fan of using drugs unless it’s absolutely necessary. And with type 2 diabetes, most of the time it’s just not necessary.
Study after study shows that it’s possible to manage—and even improve—the condition through diet and lifestyle.
If you’re currently taking rosglitazone, talk to your doctor about other options—preferably drug-free ones.
